Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
5.17
+0.05 (0.98%)
May 21, 2026, 1:11 PM EDT - Market open
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $405.96 million as of May 21, 2026. Its market cap has increased by 276.27% in one year.
Market Cap
405.96M
Enterprise Value
216.35M
1-Year Change
276.27%
Ranking
Category
Stock Price
$5.17
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has increased from $271.36M to $405.96M, an increase of 49.60%. That is a compound annual growth rate of 17.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 402.03M | -44.53% |
| Dec 31, 2025 | 724.76M | 232.99% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
| Nov 3, 2023 | 271.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fulcrum Therapeutics | 423.12M |
| Assembly Biosciences | 417.34M |
| Ovid Therapeutics | 413.56M |
| ADC Therapeutics | 412.10M |
| Sagimet Biosciences | 410.65M |
| Century Therapeutics | 405.80M |
| Lyell Immunopharma | 401.79M |
| Enanta Pharmaceuticals | 395.76M |